Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca L Meshaw

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Nuclear Medicine and Biology|May 26, 2020
Site-specific radioiodination of an anti-HER2 single domain antibody fragment with a residualizing prosthetic agentYutian Feng, Zhengyuan Zhou, Darryl McDougald, et al.
Journal of Medicinal Chemistry|November 11, 2022
Site-Specific Radiohalogenation of a HER2-Targeted Single-Domain Antibody Fragment Using a Novel Residualizing Prosthetic AgentYutian Feng, Samantha M Sarrett, Rebecca L Meshaw, et al.
Nuclear Medicine and Biology|May 4, 2024
A third generation PSMA-targeted agent [<sup>211</sup>At]YF2: Synthesis and in vivo evaluationYutian Feng, Rebecca L Meshaw, Sean W Finch, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Nuclear Medicine and Biology|May 26, 2020
Site-specific radioiodination of an anti-HER2 single domain antibody fragment with a residualizing prosthetic agentYutian Feng, Zhengyuan Zhou, Darryl McDougald, et al.
Journal of Medicinal Chemistry|November 11, 2022
Site-Specific Radiohalogenation of a HER2-Targeted Single-Domain Antibody Fragment Using a Novel Residualizing Prosthetic AgentYutian Feng, Samantha M Sarrett, Rebecca L Meshaw, et al.
Nuclear Medicine and Biology|May 4, 2024
A third generation PSMA-targeted agent [<sup>211</sup>At]YF2: Synthesis and in vivo evaluationYutian Feng, Rebecca L Meshaw, Sean W Finch, et al.
Pageof 1